Ginger Ding PhD
Director, Investment Analyst
Dr. Ding has a 10-year track record in biomedical research. She also has rich experience in grant application to various funding agencies, including NIH (RO1, Cancer Moonshot, and SPORE), DoD, Susan G. Komen, and METAvivor. She was an awardee of Susan G. Komen grant in support of her pre-clinical studies.
At Mybiogate, Dr. Ding leads a team of scientists and consultants to perform biotech industry analysis, focusing on the oncology sector. She also contributes to the content delivery on Mybiogate platform and establishment of partnerships with a variety of biotech companies and organizations.
Dr. Ding has also served as Associate Faculty for F1000, invited reviewer for 10+ science journals, as well as supervisor and former vice president of TMC consulting club (a non-profit organization of 500+ members). Prior to Mybiogate, Dr. Ding co-founded Bioscience Consulting based in Beijing, China. She worked as Research Associate at University of California, San Diego from 2012 to 2015 and MD Anderson Cancer Center from 2015 to 2018. Dr. Ding received her B.S. from Wuhan University and Ph.D. from University of Oklahoma Health Sciences Center.